However, SARS-CoV-2 can inhibit Nrf2 activation through its viral proteins, thereby weakening the cell’s ability to cope with oxidative stress, which in turn increases inflammation and tissue damage, contributing to severe COVID-19 outcomes [110]. Here, NFE2L2 is linked to COVID-19.